USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke BENITEC wurde als Wortmarke am 25.02.2003 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".
| Markenform | Wortmarke |
| Aktenzeichen | 76492931 |
| Anmeldedatum | 25. Februar 2003 |
| Veröffentlichungsdatum | 02. November 2004 |
Markeninhaber
P.O. Box 4193
St. Lucia, QLD, 4067
AU
St. Lucia, QLD, 4067
AU
Markenvertreter
Waren und Dienstleistungen
1
Diagnostic preparations for scientific and research use, namely, preparations containing synthetic nucleic acid, including synthetic DNA, cloned DNA and recombinant DNA; synthetic RNA, cloned RNA and recombinant RNA; DNA and RNA for scientific and research use in the fields of agricultural and industrial biotechnology; DNA and RNA and preparations containing DNA and/or RNA for scientific and research use in the regulation and/or expression of mammalian, human, plant, microbial and synthetic genes for use in the fields of pharmaceutical research and agricultural and industrial biotechnology; pharmaceutical and other diagnostic preparations for scientific and research use in the fields of agricultural and industrial biotechnology; pharmaceutical and other preparations for use in the field of pharmaceutical research; yeast, fungi, tissue culture of plants, and genetically modified examples thereof for scientific or research use
5
Diagnostic preparations for clinical and medical and/or veterinary laboratory use, namely, DNA and/or RNA and preparations containing DNA and/or RNA for the regulation and expression of mammalian, human, plant, microbial and synthetic genes for use in the fields of human and veterinary therapeutics; medicinal and biological preparations for clinical or medical laboratory use including preparations for the modification of gene expression; medicinal and biological preparations for pharmaceutical use in the treatment of AIDS, HIV, Hepatitis B and C, viral infections and diseases, cancers, bacterial infections, central nervous system disorders, diabetes, obesity, genetic disorders and genetic illnesses, autoimmune, inflammatory; immunodeficiency, respiratory, cardiovascular and urologic diseases; pharmaceutical and other preparations for use in the fields of human and veterinary therapeutics in the treatment of AIDS, HIV, Hepatitis B and C, viral infections and diseases, cancers, bacterial infections, central nervous system disorders, diabetes, obesity, genetic disorders and genetic illnesses, autoimmune, inflammatory; immunodeficiency, respiratory, cardiovascular and urologic diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1376492931